FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103164876> ?p ?o ?g. }

• W2103164876 endingPage "822" @default.
• W2103164876 startingPage "812" @default.
• W2103164876 abstract "Abstract Traditional treatment modalities for advanced cancer (radiotherapy, chemotherapy, or targeted agents) act directly on tumors to inhibit or destroy them. Along with surgery, these modalities are predominantly palliative, with toxicity and only modest improvements in survival in patients with advanced solid tumors. Accordingly, long-term survival rates for most patients with advanced cancer remain low, thus there is a need for cancer treatments with favorable benefit and toxicity profiles that can potentially result in long-term survival. The immune system plays a critical role in the recognition and eradication of tumor cells (“immune surveillance”), and immunotherapies based on this concept have been used for decades with some success against a few tumor types; however, most immunotherapies were limited by a lack of either substantial efficacy or specificity, resulting in toxicity. We now have a greater understanding of the complex interactions between the immune system and tumors and have identified key molecules that govern these interactions. This information has revitalized the interest in immunotherapy as an evolving treatment modality using immunotherapeutics designed to overcome the mechanisms exploited by tumors to evade immune destruction. Immunotherapies have potentially complementary mechanisms of action that may allow them to be combined with other immunotherapeutics, chemotherapy, targeted therapy, or other traditional therapies. This review discusses the concepts and data behind immunotherapies, with a focus on the checkpoint inhibitors and their responses, toxicities, and potential for long-term survival, and explores promising single-agent and combination therapies in development. Implications for Practice: Immunotherapy is an evolving treatment approach based on the role of the immune system in eradicating cancer. An example of an immunotherapeutic is ipilimumab, an antibody that blocks cytotoxic T-lymphocyte antigen-4 (CTLA-4) to augment antitumor immune responses. Ipilimumab is approved for advanced melanoma and induced long-term survival in a proportion of patients. The programmed death-1 (PD-1) checkpoint inhibitors are promising immunotherapies with demonstrated sustained antitumor responses in several tumors. Because they harness the patient's own immune system, immunotherapies have the potential to be a powerful weapon against cancer." @default.
• W2103164876 created "2016-06-24" @default.
• W2103164876 creator A5019044309 @default.
• W2103164876 creator A5075621683 @default.
• W2103164876 date "2015-06-11" @default.
• W2103164876 modified "2023-10-14" @default.
• W2103164876 title "The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment" @default.
• W2103164876 cites W103288874 @default.
• W2103164876 cites W110572178 @default.
• W2103164876 cites W1766682057 @default.
• W2103164876 cites W1853976744 @default.
• W2103164876 cites W1971208896 @default.
• W2103164876 cites W1971608284 @default.
• W2103164876 cites W1973251492 @default.
• W2103164876 cites W1979811833 @default.
• W2103164876 cites W1983986735 @default.
• W2103164876 cites W1994815971 @default.
• W2103164876 cites W2001131198 @default.
• W2103164876 cites W2001498331 @default.
• W2103164876 cites W2003427916 @default.
• W2103164876 cites W2009720434 @default.
• W2103164876 cites W2011850791 @default.
• W2103164876 cites W2012951244 @default.
• W2103164876 cites W2023082289 @default.
• W2103164876 cites W2023985105 @default.
• W2103164876 cites W2038234028 @default.
• W2103164876 cites W2038388329 @default.
• W2103164876 cites W2040956995 @default.
• W2103164876 cites W2043991982 @default.
• W2103164876 cites W2044835625 @default.
• W2103164876 cites W2046972425 @default.
• W2103164876 cites W2047353087 @default.
• W2103164876 cites W2052874737 @default.
• W2103164876 cites W2059891883 @default.
• W2103164876 cites W2061686366 @default.
• W2103164876 cites W2066671159 @default.
• W2103164876 cites W2068834940 @default.
• W2103164876 cites W2069087118 @default.
• W2103164876 cites W2070067118 @default.
• W2103164876 cites W2073989522 @default.
• W2103164876 cites W2083613163 @default.
• W2103164876 cites W2090083883 @default.
• W2103164876 cites W2095242372 @default.
• W2103164876 cites W2097995306 @default.
• W2103164876 cites W2098005365 @default.
• W2103164876 cites W2098414192 @default.
• W2103164876 cites W2099156986 @default.
• W2103164876 cites W2100086637 @default.
• W2103164876 cites W2100158834 @default.
• W2103164876 cites W2101477183 @default.
• W2103164876 cites W2103959341 @default.
• W2103164876 cites W2105484520 @default.
• W2103164876 cites W2108972938 @default.
• W2103164876 cites W2109485845 @default.
• W2103164876 cites W2111877246 @default.
• W2103164876 cites W2112069616 @default.
• W2103164876 cites W2113132543 @default.
• W2103164876 cites W2118546263 @default.
• W2103164876 cites W2118982164 @default.
• W2103164876 cites W2120426523 @default.
• W2103164876 cites W2121556079 @default.
• W2103164876 cites W2122495232 @default.
• W2103164876 cites W2123363005 @default.
• W2103164876 cites W2124427232 @default.
• W2103164876 cites W2125485324 @default.
• W2103164876 cites W2125616358 @default.
• W2103164876 cites W2128035403 @default.
• W2103164876 cites W2132923173 @default.
• W2103164876 cites W2133075384 @default.
• W2103164876 cites W2136746908 @default.
• W2103164876 cites W2136890067 @default.
• W2103164876 cites W2140111836 @default.
• W2103164876 cites W2140828776 @default.
• W2103164876 cites W2142447995 @default.
• W2103164876 cites W2143163879 @default.
• W2103164876 cites W2144401692 @default.
• W2103164876 cites W2150669821 @default.
• W2103164876 cites W2152980179 @default.
• W2103164876 cites W2153080167 @default.
• W2103164876 cites W2154391127 @default.
• W2103164876 cites W2155599713 @default.
• W2103164876 cites W2157578187 @default.
• W2103164876 cites W2160834915 @default.
• W2103164876 cites W2163184777 @default.
• W2103164876 cites W2163895585 @default.
• W2103164876 cites W2164281389 @default.
• W2103164876 cites W2170669390 @default.
• W2103164876 cites W2211214375 @default.
• W2103164876 cites W2237385549 @default.
• W2103164876 cites W2252985510 @default.
• W2103164876 cites W2267696632 @default.
• W2103164876 cites W2286032567 @default.
• W2103164876 cites W2329810662 @default.
• W2103164876 cites W2468502134 @default.
• W2103164876 cites W2471272049 @default.
• W2103164876 cites W2476006635 @default.
• W2103164876 cites W2522577924 @default.
• W2103164876 cites W2526642223 @default.

• next